Literature DB >> 22301635

Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.

Erwan Piriou1, Amolo S Asito, Peter O Sumba, Nancy Fiore, Jaap M Middeldorp, Ann M Moormann, Robert Ploutz-Snyder, Rosemary Rochford.   

Abstract

BACKGROUND: Infection with Epstein-Barr virus (EBV) early in life and repeated malaria exposure have been proposed as risk factors for endemic Burkitt lymphoma (eBL).
METHODS: Infants were enrolled from 2 rural sites in Kenya: the Kisumu District, where malaria transmission is holoendemic and risk for eBL is high, and the Nandi District, where malaria transmission is limited and the risk for eBL is low. Blood samples were taken from infants through 2 years of age to measure EBV viral load, EBV antibodies, and malaria parasitemia.
RESULTS: We observed a significantly younger age at time of primary EBV infection in children from Kisumu compared with children from Nandi (mean age, 7.28 months [±0.33 SEM] in Kisumu vs 8.39 months [±0.26 SEM] in Nandi), with 35.3% of children in Kisumu infected before 6 months of age. To analyze how different predictors affected EBV viral load over time, we performed multilevel mixed modeling. This modeling revealed that residence in Kisumu and younger age at first EBV infection were significant predictors for having a higher EBV viral load throughout the period of observation.
CONCLUSIONS: Children from a region at high risk for eBL were infected very early in life with EBV, resulting in higher viral loads throughout infancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301635      PMCID: PMC3282570          DOI: 10.1093/infdis/jir872

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa.

Authors:  R W Snow; J A Omumbo; B Lowe; C S Molyneux; J O Obiero; A Palmer; M W Weber; M Pinder; B Nahlen; C Obonyo; C Newbold; S Gupta; K Marsh
Journal:  Lancet       Date:  1997-06-07       Impact factor: 79.321

3.  Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children.

Authors:  Ann M Moormann; Kiprotich Chelimo; Odada P Sumba; Mary L Lutzke; Robert Ploutz-Snyder; Duane Newton; James Kazura; Rosemary Rochford
Journal:  J Infect Dis       Date:  2005-03-09       Impact factor: 5.226

4.  Epstein-Barr virus (EBV) infection in infancy.

Authors:  K H Chan; J S Tam; J S Peiris; W H Seto; M H Ng
Journal:  J Clin Virol       Date:  2001-04       Impact factor: 3.168

5.  Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.

Authors:  Ann M Moormann; Kiprotich Chelimo; Peter O Sumba; Daniel J Tisch; Rosemary Rochford; James W Kazura
Journal:  J Infect Dis       Date:  2007-02-06       Impact factor: 5.226

6.  Relationships between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast.

Authors:  C N Mbogo; R W Snow; C P Khamala; E W Kabiru; J H Ouma; J I Githure; K Marsh; J C Beier
Journal:  Am J Trop Med Hyg       Date:  1995-03       Impact factor: 2.345

7.  Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya.

Authors:  Erwan Piriou; Rhonda Kimmel; Kiprotich Chelimo; Jaap M Middeldorp; Peter Sumba Odada; Robert Ploutz-Snyder; Ann M Moormann; Rosemary Rochford
Journal:  J Med Virol       Date:  2009-06       Impact factor: 2.327

8.  Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area.

Authors:  David M Menge; Kacey C Ernst; John M Vulule; Peter A Zimmerman; Hongfei Guo; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

9.  Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.

Authors:  W M van Grunsven; W J Spaan; J M Middeldorp
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

10.  A molecular link between malaria and Epstein-Barr virus reactivation.

Authors:  Arnaud Chêne; Daria Donati; André Ortlieb Guerreiro-Cacais; Victor Levitsky; Qijun Chen; Kerstin I Falk; Jackson Orem; Fred Kironde; Mats Wahlgren; Maria Teresa Bejarano
Journal:  PLoS Pathog       Date:  2007-06       Impact factor: 6.823

View more
  65 in total

1.  Age of infection and risk of virally associated cancers: new clues to an old puzzle.

Authors:  Rachel Bagni; Denise Whitby
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

Review 2.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 3.  Animal models of tumorigenic herpesviruses--an update.

Authors:  Dirk P Dittmer; Blossom Damania; Sang-Hoon Sin
Journal:  Curr Opin Virol       Date:  2015-10       Impact factor: 7.090

4.  The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.

Authors:  Anna E Coghill; Carla Proietti; Allan Hildesheim; Denise L Doolan; Sam M Mbulaiteye; Zhiwei Liu; Lutz Krause; Jeff Bethony; Ludmila Prokunina-Olsson; Adeola Obajemu; Francis Nkrumah; Robert J Biggar; Kishor Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-16       Impact factor: 4.254

5.  Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.

Authors:  Soren Gantt; Jackson Orem; Elizabeth M Krantz; Rhoda Ashley Morrow; Stacy Selke; Meei-Li Huang; Joshua T Schiffer; Keith R Jerome; Annet Nakaganda; Anna Wald; Corey Casper; Lawrence Corey
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

6.  HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.

Authors:  Kee Thai Yeo; Paula Embury; Timothy Anderson; Peter Mungai; Indu Malhotra; Christopher King; James Kazura; Arlene Dent
Journal:  J Immunol       Date:  2019-01-23       Impact factor: 5.422

7.  Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load.

Authors:  Henry H Balfour; Priya Verghese
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

8.  Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection.

Authors:  Arnold Reynaldi; Timothy E Schlub; Erwan Piriou; Sidney Ogolla; Odada P Sumba; Ann M Moormann; Rosemary Rochford; Miles P Davenport
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

9.  Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.

Authors:  Jennifer A Slyker; Corey Casper; Kenneth Tapia; Barbra Richardson; Lisa Bunts; Meei-Li Huang; Elizabeth Maleche-Obimbo; Ruth Nduati; Grace John-Stewart
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

10.  AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus.

Authors:  Joel R Wilmore; Amolo S Asito; Chungwen Wei; Erwan Piriou; P Odada Sumba; Iñaki Sanz; Rosemary Rochford
Journal:  Int J Cancer       Date:  2014-08-19       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.